Review scope
Included studies compared screening with no screening, delayed screening, or usual care, or assessed diagnostic accuracy of screening in asymptomatic adults ≥ 65 years of age without known vision impairment (based on corrected vision) who had not sought vision assessment; or compared vision acuity treatments for mild to moderate impairment (better than 20/200 but worse than 20/40). Screening and diagnostic studies in specialty settings and treatment studies in patients who had other causes of vision loss were excluded. 
Review methods

Main results
The main results are in the Table. The Amsler grid, screening questions/questionnaires, a vision screening tool provided by computer or flip chart, and the Minimum Data Set 2.0 Vision Patterns section score had poor diagnostic accuracy. Several treatments are efficacious for eye disorders (Table) , but their benefits have not been linked to early detection as a result of screening older adults.
Conclusion
Based on the findings of this systematic review, the US Preventive Services Task Force made no recommendation on screening for impaired vision acuity in older adults (current evidence is insufficient to assess the balance of benefits and harms).* 
*US Preventive Services
Commentary
The ambitious review by Chou and colleagues assesses a screening-treatment-outcome pathway and gives a counterintuitive result: Screening detects more vision problems than usual care (27% vs 3% in 1 study), early treatment is effective, but there is no evidence that screening benefits older adults.
This apparent disconnect may simply relate to sample size. Most healthy older adults do not have untreated vision problems, and available treatments are only modestly effective. Thus, demonstrating benefit would require larger populations than have been studied. The review focused on refractive error, cataracts, and macular degeneration, which are the most common-but not the onlycauses of disabling vision problems in older adults.
Heterogeneity in vision problems may explain why screening questions seemed to have poor accuracy. Screening questions try to capture all vision problems, whereas the comparator screening test (Snellen chart) is specific to vision acuity.
Useful interventions are not always direct treatments. If screening detects a progressive vision problem and the patient is referred to a low-vision service, has home adaptations, and makes an informed decision to stop driving, screening has arguably been successful. However, most available studies use hard clinical endpoints (e.g., vision acuity) and are not designed to assess patient outcomes with this level of granularity.
To interpret this review, clinical context is important. It focused on asymptomatic older adults in primary care settings. We should avoid extrapolating the results to vision screening of frail elderly persons or comprehensive geriatric assessment. In those settings, the prevalence of potentially disabling vision symptoms will be higher and screening will more likely show benefit. The review conclusion of "insufficient evidence" for screening is reasonable. It recognizes that better evidence for clinical and economic effects is needed before vision screening becomes part of a routine older adult health-check. The conclusion does not preclude active case-finding in high-risk populations nor comprehensive assessment of older adults presenting with vision symptoms.
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Questions Findings
Benefits of screening
Screening did not differ from no screening, usual care, or delayed screening for vision or other clinical outcomes at 6 mo to 5 y (3 RCTs, n = 4728). 
Therapeutics
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